NASHVILLE, Tenn., June 21, 2021 /PRNewswire/ --Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released a series of case reports describing the effectiveness of Vibativ® (telavancin) in treating secondary bacterial infections in COVID-19 patients – particularly those with other significant health problems, such as obesity, diabetes and heart disease.
Search / 257 results found Showing: 1-10 of 257
A new analysis of blood samples from 24,000 Americans taken early last year is the latest and largest study to suggest that the new coronavirus popped up in the U.S. in December 2019.
COVINGTON, Ky., June 11, 2021 /PRNewswire/ -- Gravity Diagnostics has been chosen as a 2021 Fast 55 finalist by the Cincinnati Business Courier. The Fast 55 Award is granted to privately held companies in the region with the fastest growth in the past year.
On May 4, President Joe Biden set a goal of getting at least one COVID-19 vaccine dose into the arms of 70% of adults by July 4.
DURHAM, N.C., May 26, 2021 /PRNewswire/ -- Inhalon Biopharma, a start-up immunotherapy company developing an inhaled "muco-trapping" antibody platform for treating a variety of acute respiratory infections (ARI), today announced that it has been awarded a $7 million contract by the U.S. Army Medical Research & Development Command (USAMRDC) to conduct a placebo-controlled Phase 1/2a study of IN-006 in COVID-19 outpatients. IN-006 is a potent, neutralizing monoclonal antibody being investigated for the treatment of COVID-19. Initial results of this study are expected in 2022.
DORAVILLE, Ga., May 11, 2021 /PRNewswire/ -- Throughout the pandemic, the world has focused heavily on disinfecting surfaces — but the latest CDC guidance reveals this shouldn't be the top priority. When it comes to beating COVID, businesses and individuals alike must focus on mitigating the risk of airborne transmission.
NASHVILLE, Tenn., May 11, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and first quarter 2021 financial results. Net revenues from continuing operations during the quarter were $10.5 million, a 26.5% increase over the prior year period. The company also recorded an additional $500,000 in revenue during the first quarter associated with divested product rights for two brands it is no longer distributing.
For more than a year now, Dr. Darshan Shah has been on the front lines in the local fight against the COVID-19 pandemic.
After a rise in new COVID-19 infections and hospitalizations last month, Northeast Tennessee is on pace to see its fewest new infections since…
Northeast Tennessee reported 50 new COVID-19 infections on Tuesday, with none reported in Sullivan County — the first time the county hasn’t r…